Ignite Creation Date:
2024-05-06 @ 4:56 PM
Last Modification Date:
2024-10-26 @ 2:18 PM
Study NCT ID:
NCT05132504
Status:
RECRUITING
Last Update Posted:
2024-02-15
First Post:
2021-10-27
Brief Title:
Neoadjuvant Folfirinox Combined With Pembrolizumab Followed by Surgery for Patients With Resectable Pancreatic Cancer
Sponsor:
Baylor College of Medicine
Organization:
Baylor College of Medicine
Organization Data
Organization:
Baylor College of Medicine
Class:
OTHER
Study ID:
H-50168
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Baylor College of Medicine
Lead Sponsor Class:
OTHER
Responsible Party:
Ernest Ramsay Camp
Responsible Party Title:
Professor and Chief Division of Surgical Oncology
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Baylor College of Medicine
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| The Methodist Hospital Research Institute | OTHER |
| Merck Sharp Dohme LLC | INDUSTRY |